Biomics Biopharma (ASX:BBM) Total Equity: A$0.00 Mil (As of . 20)


What is Biomics Biopharma Total Equity?

Biomics Biopharma ASX:BBM Total Equity is A$0.00 Mil as of . 20.

Biomics Biopharma's total equity for the quarter that ended in . 20 was A$0.00 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Biomics Biopharma Total Equity Historical Data

* Premium members only.

The historical data trend for Biomics Biopharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma Total Equity Chart

Biomics Biopharma Annual Data
Trend
Total Equity

Biomics Biopharma Semi-Annual Data
Total Equity

Biomics Biopharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Biomics Biopharma's Total Equity for the fiscal year that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

Biomics Biopharma's Total Equity for the quarter that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of A$0.00 Mil mean?
Biomics Biopharma (ASX:BBM) has a Total Equity of A$0.00 Mil as of . 20. The total amount of equity as record on a company's balance sheet. View historical data for Biomics Biopharma and its competitors.
Is Biomics Biopharma's Total Equity too high?
Biomics Biopharma's current Total Equity is A$0.00 Mil.
How does Biomics Biopharma's Total Equity compare to competitors?
Biomics Biopharma's Total Equity of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Biomics Biopharma and its competitors. Biomics Biopharma's current Total Equity is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomics Biopharma stock overvalued right now?
Biomics Biopharma (ASX:BBM) has a current Total Equity of A$0.00 Mil. The current Total Equity is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Biomics Biopharma (ASX:BBM), the current Total Equity is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomics Biopharma Business Description

Address 1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.